Celyad Oncology SA (EBR:CYAD)
Belgium
· Delayed Price · Currency is EUR 0.5480
+0.0040 (0.74%)
Mar 28, 2025, 5:25 PM CET
Celyad Oncology Revenue
Celyad Oncology had revenue of 14.00K EUR in the half year ending June 30, 2024. This brings the company's revenue in the last twelve months to 72.00K, up 63.64% year-over-year. In the year 2023, Celyad Oncology had annual revenue of 102.00K.
Revenue (ttm)
72.00K
Revenue Growth
+63.64%
P/S Ratio
258.79
Revenue / Employee
4.00K
Employees
19
Market Cap
21.96M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| argenx SE | 2.17B |
| UCB SA | 6.15B |
| Financière de Tubize | 13.26K |
| Fagron NV | 871.96M |
| Ion Beam Applications | 465.75M |
| Nyxoah | 4.52M |
| Onward Medical | -188.00K |
| Hyloris Pharmaceuticals | 10.04M |